Protocolo basado en la evidencia para el diagnóstico y tratamiento del paciente adulto con depresión en el Hospital Universitario Nacional de Colombia

ilustraciones, tablas

Autores:: Morales Pinilla, Luisa Fernanda

Tipo de recurso:

Fecha de publicación:: 2021

Institución:: Universidad Nacional de Colombia

Repositorio:: Universidad Nacional de Colombia

Idioma:: spa

id	UNACIONAL2_256635b455fd197fb5da55cad3d99a3e
oai_identifier_str	oai:repositorio.unal.edu.co:unal/81106
network_acronym_str	UNACIONAL2
network_name_str	Universidad Nacional de Colombia
repository_id_str
dc.title.spa.fl_str_mv	Protocolo basado en la evidencia para el diagnóstico y tratamiento del paciente adulto con depresión en el Hospital Universitario Nacional de Colombia
dc.title.translated.eng.fl_str_mv	Evidence-based protocol for the diagnosis and treatment of adult patients with depression at the Colombia National University Hospital
title	Protocolo basado en la evidencia para el diagnóstico y tratamiento del paciente adulto con depresión en el Hospital Universitario Nacional de Colombia
spellingShingle	Protocolo basado en la evidencia para el diagnóstico y tratamiento del paciente adulto con depresión en el Hospital Universitario Nacional de Colombia 610 - Medicina y salud::616 - Enfermedades Depresión Depression Depresión Trastorno depresivo recurrente Episodio depresivo Protocolo Lineamientos Depression Recurrent depressive disorder Depressive episode Protocol Recommendations
title_short	Protocolo basado en la evidencia para el diagnóstico y tratamiento del paciente adulto con depresión en el Hospital Universitario Nacional de Colombia
title_full	Protocolo basado en la evidencia para el diagnóstico y tratamiento del paciente adulto con depresión en el Hospital Universitario Nacional de Colombia
title_fullStr	Protocolo basado en la evidencia para el diagnóstico y tratamiento del paciente adulto con depresión en el Hospital Universitario Nacional de Colombia
title_full_unstemmed	Protocolo basado en la evidencia para el diagnóstico y tratamiento del paciente adulto con depresión en el Hospital Universitario Nacional de Colombia
title_sort	Protocolo basado en la evidencia para el diagnóstico y tratamiento del paciente adulto con depresión en el Hospital Universitario Nacional de Colombia
dc.creator.fl_str_mv	Morales Pinilla, Luisa Fernanda
dc.contributor.advisor.none.fl_str_mv	Calvo, José Manuel Carlos Fernando, Grillo Ardila
dc.contributor.author.none.fl_str_mv	Morales Pinilla, Luisa Fernanda
dc.subject.ddc.spa.fl_str_mv	610 - Medicina y salud::616 - Enfermedades
topic	610 - Medicina y salud::616 - Enfermedades Depresión Depression Depresión Trastorno depresivo recurrente Episodio depresivo Protocolo Lineamientos Depression Recurrent depressive disorder Depressive episode Protocol Recommendations
dc.subject.other.none.fl_str_mv	Depresión Depression
dc.subject.proposal.spa.fl_str_mv	Depresión Trastorno depresivo recurrente Episodio depresivo Protocolo Lineamientos
dc.subject.proposal.eng.fl_str_mv	Depression Recurrent depressive disorder Depressive episode Protocol Recommendations
description	ilustraciones, tablas
publishDate	2021
dc.date.issued.none.fl_str_mv	2021
dc.date.accessioned.none.fl_str_mv	2022-03-01T23:33:01Z
dc.date.available.none.fl_str_mv	2022-03-01T23:33:01Z
dc.type.spa.fl_str_mv	Trabajo de grado - Especialidad Médica
dc.type.driver.spa.fl_str_mv	info:eu-repo/semantics/masterThesis
dc.type.version.spa.fl_str_mv	info:eu-repo/semantics/acceptedVersion
dc.type.content.spa.fl_str_mv	Text
dc.type.redcol.spa.fl_str_mv	http://purl.org/redcol/resource_type/TM
status_str	acceptedVersion
dc.identifier.uri.none.fl_str_mv	https://repositorio.unal.edu.co/handle/unal/81106
dc.identifier.instname.spa.fl_str_mv	Universidad Nacional de Colombia
dc.identifier.reponame.spa.fl_str_mv	Repositorio Institucional Universidad Nacional de Colombia
dc.identifier.repourl.spa.fl_str_mv	https://repositorio.unal.edu.co/
url	https://repositorio.unal.edu.co/handle/unal/81106 https://repositorio.unal.edu.co/
identifier_str_mv	Universidad Nacional de Colombia Repositorio Institucional Universidad Nacional de Colombia
dc.language.iso.spa.fl_str_mv	spa
language	spa
dc.relation.references.spa.fl_str_mv	Ministerio de Sanidad, Servicios Sociales e Igualdad. (2014). Guía de Práctica Clínica Sobre el Manejo de la Depresión en el Adulto. Galicia: Agencia de Evaluación de Tecnologías Sanitarias de Galicia, avalia-t. Conselleria de Sanidad, Ministerio de Sanidad, Servicios Sociales e Igualdad. National Institute for Health & Clinical Excellence. (2019). DEPRESSION. The Nice Guideline On The Treatment And Management Of Depression In Adults. London: The British Psychological Society and The Royal College of Psychiatrists. Group, T. G. (2004). The Grading of Recommendations Assessment, Development and Evaluation. Obtenido de GRADE: https://www.gradeworkinggroup.org/ Research, C. I. (2009). APPRAISAL OF GUIDELINES FOR RESEARCH & EVALUATION II. McMaster University, Hamilton, Ontario, Canada: AGREE Next Steps Consortium. Colombiano, G. d. (2014). Guía Metodológica para la elaboración de Guías de Práctica Clínica con Evaluación Económica en el Sistema General de Seguridad Social en Salud Colombiano. Obtenido de https://www.iets.org.co/Archivos/62/Gu%C3%ADa%20Metodol%C3%B3gica%20El aboraci%C3%B3n%20de%20GPC%20con%20Evaluaci%C3%B3n%20Econ%C3%B3mi ca%20en%20el%20Sist%20Seguridad%20Social%20y%20SaludVersi%C3%B3n%20final%20completa.PDF Patricia B. Burns, R. J. (2011). The Levels of Evidence and their role in Evidence-Based Medicine. Plast Reconstr Surg, 305-311. Vallejo-Ortega MT, S.-P. R.-A.-P.-S.-C. (2016). Manual Metodológico para la elaboración de protocolos clínicos en el Instituto Nacional de Cancerología. Bogotá: Instituto Nacional de Cancerología. James Atkinson, Y. C.-S. (2007). Natural Ventilation for Infection Control in Health-Care Settings. Switzerland: WHO Publication/Guidelines. Moussavi, S. C. (2007). Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet, 370, 851-858. Cassano, P. &. (2002). Depression and public health: an overview. . Journal of Psychosomatic Research, 53., 849-857. Heilbron, N., Compton, J., & Goldston, D. (2010, 41). The Problematic Label of Suicide Gesture: Alternatives for Clinical Research and Practice. Professional Psychology, Research and Practice, 221-227. Shea, S. C. (2002). La entrevista psiquiátrica. El arte de comprender. . Madrid, España.: Ediciones Harcourt Pim Cuijpers, A. T. (March 14, 2012). Preventing Depression. A Global Priority. Journal of the American Medical Association., Vol 307, No. 10. Stockings EA, D. L. (2016). Preventing depression and anxiety in young people: a review of the joint efficacy of universal, selective and indicated prevention. Psychlogical Medicine, 46:11-26. Brugha, T. W. (2000). Pragmatic randomized trial of antenatal intervention to prevent post-natal depression by reducing psychosocial risk factors. Psychological Medicine, 30:1273-1281. Van Zoonen K, B. C. (2014). Preventing the onset of major depressive disorder: a metaanalytic review of psychological interventions. International Journal of Epidemiology., 43:318-329. Willemse GRWM, S. F. (2004). Minimal contact psychotherapy for sub-threshold depression in primary care: a randomised trial. Br J Psychiatry, 185:416-421. Van ’t Veer-Tazelaar PA, v. M. (2009). Stepped-care prevention of anxiety and depression in late life: a randomized controlled trial. . Archives of General Psychiatry, 66:297- 304 Fornés Vives, J. (2003). Enfermeria en Salud Mental. Como cuidar al cuidador. Ian Colman, P. K. (2011, Nov 22). Predictors of long-term prognosis of depression. Canadian Medical Association Journal, 183(17): 1969-1976. Christoph Kraus, B. K. (2019). Prognosis and improved outcomes in major depression: a review. Translational Psychiatry, 9:127. Stahl, S. M. (2014). Psicofarmacología Esencial de Stahl. Guía del Prescriptor. Quinta Edición. New York, USA: Aulamédica. Formación en salud Organización Mundial de la Salud. (Marzo de 2020). Temas de Salud: Depresión. Obtenido de Sitio Web Mundial. Organización Mundial de la Salud.: https://www.who.int/topics/depression/es/ Organización Panamericana de la Salud. (30 de Marzo de 2017). "Depresión: hablemos", dice la OMS, mientras la depresión encabeza la lista de causas de enfermedad. Obtenido de OPS Web Site: https://www.paho.org/hq/index.php?option=com_content&view=article&id=1310 2:depression-lets-talk-says-who-as-depression-tops-list-of-causes-of-illhealth&Itemid=1926&lang=es Organización Panamericana de la Salud, Oficina Sanitaria Panamericana. (1992). Clasificación Estadística Internacional de Enfermedades y Problemas Relacionados con la Salud. Décima Revisión. Washington, D.C. E.U.A: Oficina Regional de la Organización Mundial de la Salud Ministerio de Salud Y Protección Social de Colombia, Departamento Administrativo de Ciencia, Tecnología e Innovación. (2015). Encuesta Nacional de Salud Mental 2015 Tomo I. Bogotá, Colombia. Ministerio de Salud y Protección Social de Colombia, Colciencias. (2013). Guía de Práctica Clínica. Detección Temprana y Diagnóstico del Episodio Depresivo y Trastorno Depresivo Recurrente en Adultos. Bogotá, Colombia Association, American Psychiatric. (2014). Manual Diagnóstico y Estadístico de los Trastornos Mentales. DSM-5. 5 Edición. Virginia, Estados Unidos.: Editorial Médica Panamericana. Ministerio de Salud y Protección Social de Colombia, SISPRO. (Marzo de 2020). Sistema Integrado de Información de la Protección Social, Observatorio Salud Mental. Obtenido de SISPRO Web Site: http://rssvr2.sispro.gov.co/ObsSaludMental/ Ministerio de Salud y Protección Social, Pontificia Universidad Javeriana. . (2015). Depresión. Protocolo de Prevención y Actuacion en el Entorno Laboral. . Bogotá, Colombia.: Fundación Cultural Javeriana de Artes Gráficas - JAVEGRAF Agency for Healthcare Research and Quality U.S. Department of Health and Human Services. (2013). Screening ofr Suicide Risk in Primary Care: A Systematic Evidence Review for the U.S. Preventive Service Task Force. Portland: Agency for Healthcare Research and Quality U.S. World Health Organization. Regional Office for Europe. (2016). Preventing depression in the WHO European Region. Marmorvej, Copenhagen, Denmark: Netherlands Institute of Mental Health and Addiction. World Health Organization Ministerio de Salud y Protección Social. Organización Internacional para las Migraciones. (2015). Manual de Cuidado a Cuidadores de Personas con Trastornos Mentales y/o Enfermedades Crónicas Discapacitantes. Ministerio del Trabajo. (22 de Julio de 2019). Resolución Número 2404 de 2019. Colombia Ministerio de Trabajo. (2015, Diciembre). Protocolo de Acciones de Promoción, Prevención e Intervención de los Factores Psicosociales y sus Efectos en el Entorno Laboral. Bogotá D.C, Colombia: Fundación Cultural Javeriana de Artes Gráficas - JAVEGRAF. ONU Migración, Ministerio de Salud y Protección Social. (s.f.). Clasificación Internacional del Funcionamiento, de la Discapacidad y de la Salud- CIF- Marco Conceptual de la Certificación y Registro de Discapacidad. Creative Commons The American Psychological Association . (2019). Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts American Psychological Association Guideline Development Panel for the Treatment of Depressive Disorders. NE, Washington D.C.: The American Psychological Association (APA) Improvement, I. f. (2016). Adult Depression in Primary Care. ICSI Health Care Guideline Kroenke K, S. R. (2001). he PHQ-9: validity of a brief depression severity measure. J Gen Intern Med , 16:606-13. O'Connor AM, B. C. (2007). Do patient decision aids meet effectiveness criteria of the international patient decision aid standards collaboration? A systematic review and meta-analysis. Med Decis Making, 27:554-74. Brown, R. A. (1984). A psychoeducational approach to the treatment of depression: Comparison of group, individual, and minimal contact procedures. . Journal of Consulting and Clinical Psychology, 52(5), 774–783. Richards, D. A. (2008). Collaborative care for depression in UK primary care: a randomized comtrolled trial. Psychological Medicine, 38, 279–287. Williams, J. M. (2008). Mindfulness-based cognitive therapy: further issues in current evidence and future research. Journal of Consulting and Clinical Psychology, 76, 524–529. Christensen, H. G. (2004). Delivering interventions for depression by using the internet: randomised controlled trial. British Medical Journal, 328, 265–268. Spek, V. (2007). Internet-based cognitive behaviour therapy for subthreshold depression in people over 50 years old. Ridderprint. McCrone, P. C. (2003). Cost- utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy. European Journal of Neurology, 10, 687–694. Kaltenthaler, E. P. (2008). Computerised cognitive- behavioural therapy for depression: systematic review. British Journal of Psychiatry, 193, 181–184 Dunn AL, M. H. (2005). Exercise treatment for depression: efficacy and dose response. Am J Prev Med, 28:1-8 Babyak M, B. J. (2000). Exercise treatment for major depression: maintenance of therapeutic benefit at 10 months. Psychosom Med, 62:633-38. Schuch FB, V.-M. M. (2011). Exercise and severe depression: prelimi- nary results of an add-on study. . J Affect Disord, 133:615-18. Cooney GM, D. K. (2013). Exercise for depression. Cochrane Database of Systematic Reviews , CD004366. Cuijpers P, S. M. (2014b). Adding psychotherapy to antidepressant medication in depression and anxiety disorders: a meta-analysis. World Psychiatry, 13:56-67. Churchill R, M. T. (2013). 'Third wave' cognitive and behavioural therapies versus treatments as usual for depression. Cochrane Database Syst Rev, (10)CD008705. van Hees ML, R. T. (2013). The effectiveness of individual interpersonal psycho- therapy as a treatment for major depressive disorder in adult outpatients: a systematic review. BMC Psychiatry , 13:22 Jakobsen JC, H. J. (2012a). Effects of cognitive therapy versus interpersonal psychotherapy in patients with major depressive disorder: a systematic review of randomized clinical trials with meta-analyses and trial sequential analyses. . Psychol Med , 42:1343-57. McCarney RW, S. J. (2012). Effectiveness of mindfulness-based therapies in reducing symptoms of depression: a meta-analysis. Eur J Psychotherapy Couns, 14:279-99. Pim Cuijpers, T. D. (2011b). Self-Guided Psychological Treatment for Depressive Symptoms: A Meta-Analysis. Plos One. Jakobsen JC, H. J. (2011a). The effect of interpersonal psychotherapy and other psychodynamic therapies versus 'treatment as usual' in patients with major depressive disorder. PLoS One , 6:e19044. Flückiger C, D. R. (2014). Enduring effects of evidence-based psychotherapies in acute depression and anxiety disorders versus treatment as usual at follow-up: a longitudinal meta-analysis. Clin Psychol Rev, 34:367-75. Okumura Y, I. K. (2014). Efficacy and acceptability of group cognitive behavioral therapy for depression: a systematic review and meta-analysis. J Affect Disord , 164:155-64. JAN SCOTT, S. P. (2003). Use of cognitive therapy for relapse prevention in chronic depression in chronic depression Cost-effectiveness study . BRITI SH JOURNA L O F P SYCHIATRY, 182, 221-227. Charles F. Reynolds III, M., Ellen Frank, P., James M. Perel, P., & al, e. (1999). Nortriptyline and Interpersonal Psychotherapy as Maintenance Therapies for Recurrent Major Depression. JAMA, 281(1):39-45. H C Schulberg 1, M. R. (1996). Treating major depression in primary care practice. Eightmonth clinical outcomes. Arch Gen Psychiatry ., 53(10):913-9. Frank, E. &. (1990). Interpersonal psychotherapy for depression: Overview, clinical efficacy, and future directions. Clinical Psychology: Science and Practice, 2(4), 349– 369. Mazzucchelli T, K. R. (2009). Behavioral activation treatments for depression in adults: a meta- analysis and review. Cin Psychol Sci Prac , 16:383-411 Pim Cuijpers, A. v. (2007). Behavioral activation treatments of depression: a meta-analysis. Clin Psychol Rev ., 27(3):318-26. Sona Dimidjian, S. D. (2006). Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol ., 74(4):658-70. Pim Cuijpers, G. A. (2011a). Psychological treatment of depression: results of a series of meta-analyses. Nord J Psychiatry, 65(6):354-64. Sheffield, J. S. (2006). Evaluation of universal, indicated, and combined cognitivebehavioral approaches to the prevention of depression among adlescents. Journal of Consulting and Clinical Psychology., 74:66-79. Pim Cuijpers, E. K. (2014a). Managing depression in older age: psychological interventions. Epub. Guy Bodenmann, B. P. (2008). Effects of coping-oriented couples therapy on depression: a randomized clinical trial. J Consult Clin Psychol ., 76(6):944-54. N Bedi, C. C. (2000). Assessing effectiveness of treatment of depression in primary care. Partially randomised preference trial. Br J Psychiatry ., 177:312-8. Jeanne C Watson, L. B. (2003). Comparing the effectiveness of process-experiential with cognitive-behavioral psychotherapy in the treatment of depression. J Consult Clin Psychol . , 71(4):773-81 RHONDA N. GOLDMAN, L. S. (2006). The effects of adding emotion-focused interventions to the therapeutic relationship in the treatment of depression. Psychotherapy Research , 16(5):537-549. Greenberg, L. S. (1998). Experiential therapy of depression: Differential effects of clientcentered relationship conditions and process experiential interventions. . Psychotherapy Research, 8(2), 210–224. Friedli, K. K. (2000). The economics of employing a counsellor in general practice: analysis of data from a randomised controlled trial. British Journal of General Practice, 50, 276–283. Simpson, S. C. (2003). A randomized controlled trial to evaluate the effectiveness and costeffectiveness of psychodynamic counselling for general practice patients with chronic depression. Psychological Medicine, 33, 229–239. Van, H. L. (2008). Predicting the outcome of antidepressants and psychotherapy for depression: a qualitative, systematic review. . Harvard Review of Psychiatry, 16, 225–234. Jouko K Salminen, H. K.-H. (2008). Short-term psychodynamic psychotherapy and fluoxetine in major depressive disorder: a randomized comparative study. Psychother Psychosom ., 77(6):351-7. McLean, P. D. (1979). Clinical depression: Comparative efficacy of outpatient treatments. Journal of Consulting and Clinical Psychology, 47(5), 818–836. Giuseppe Maina, G. R. (2008). Brief dynamic therapy combined with pharmacotherapy in the treatment of major depressive disorder: long-term results. J Affect Disord ., 114(1-3):200-7 Kool, S. D. (2003). Changes in personality pathology after pharmacotherapy and combined therapy for depressed patients. Journal of Personality Disorders, 17(1), 60–72. Association, A. P. (2010). PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder. American Psychiatric Association. Katon W, R. P. (1996). A multifaceted intervention to improve treatment of depression in primary care. . Arch Gen Psychiatry, 53:924-32 Fournier JC, D. R. (2010). Antidepressant drug effects and depression severity: a patientlevel meta-analysis. . JAMA, 303:47-53. Keller MB, K. J. (1998). Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial. JAMA, 280:1665-72. RMA., H. (2001). Clinical importance of long-term antidepressant treatment. Br J Psychiatry Suppl, 179:S4-S8. JF., G. (1993). Antidepressant maintenance medications: when to discontinue and how to stop. J Clin Psychiatry , 54:39-47. Trivedi MH, K. B. (2001). Algorithm for the treatment of chronic depression. J Clin Psychiatry , 62:22- 29. Barbey, J. T. (1998). SSRI safety in overdose. Journal of Clinical Psychiatry,, 59 (Suppl. 15), 42–48. Goeringer, K. E. (2000). Post mortem forensic toxicology of selective serotonin reuptake inhibitors: a review of pharmacology and report of 168 cases. . Journal of Forensic Sciences,, 45, 633–648. Cohen, H. W. (2000). Excess risk of myocardial infarction in patients treated with antidepressant medication: association with use of tricyclic agents. American Journal of Medicine, 108, 2–8. Meier, C. R. (2001). Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction. British Journal of Clinical Pharmacology, 52, 179–184. Sauer, W. H. (2001). elective serotonin reuptake inhibitors and myocardial infarction. Circulation, 104, 1894–1898 Musselman, D. L. (1998). The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Archives of General Psychiatry, 55, 580–592. Pollock, B. G.-T. (2000). Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. Journal of Clinical Psychopharmacology, 20, 137–140. Rasmussen, S. L. (1999). Cardiac safety of citalopram: prospective trials and retrospective analyses. Journal of Clinical Psycho- pharmacology, , 19, 407–415. Zivin K, P. P. (2013). Evaluation of the FDA warning against prescribing citalopram at doses exceeding 40 mg. Am J Psychiatry, 170:642-50 Zivin K, P. P. (2013). Evaluation of the FDA warning against prescribing citalopram at doses exceeding 40 mg. Am J Psychiatry, 170:642-50 Steven P. Roosen, M., & and Kristen M. Suthers, M. (1998). Antidepressant Response in Late-life Depression. J Clinic Psychiatry, 59 (Suppl 10). Strik, J. J. (2000). Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebocontrolled trial. Psychosomatic Medicine, 62, 783–789. Hewer, W. R. (1995). Cardiovascular effects of fluvoxamine and maprotiline antidepressant treatment: effects on cognitive function and psychomotor performance. International Clinical Psychopharmacology, 15, 305–318 Garnier, R. A. (1993). Acute fluvoxamine poisoning. Journal of International Medical Research, 21, 197–208. Glassman, A. H. (2002). Sertraline treatment of major depression in patients with acute MI or unstable angina. Journal of the American Medical Association, 288, 701–709. Cipriani, A. F. (2009). Comparative efficacy and acceptability of 12 new generation antidepressants: a multiple treatments meta- analysis. The Lancet, 373, 746–758. Roose, S. P. (1989). Cardiovascular effects of tricyclic antidepressants in depressed patients with and without heart disease. Journal of Clinical Psychiatry Monograph, 7, 1–19. Glassman, A. H. (1993). The safety of tricyclic antidepressants in cardiac patients. Risk– benefit reconsidered. Journal of the American Medical Association, 269, 2673– 2675. Roose, S. P. (1987). Tricyclic antidepressants in depressed patients with cardiac conduction disease. Archives of General Psychiatry, 44, 273–275. Shah, R. U. (2001). Trends in deaths from drug overdose and poisoning in England and Wales 1993–1998. Journal of Public Health Medicine, 23, 242–246. A Wade, K. G. (2007). A comparative study of the efficacy of acute and continuation treatment with escitalopram versus duloxetine in patients with major depressive disorder. Curr Med Res Opin ., Jul;23(7):1605-14. Schatzberg, A. F. (2002). Pharmacological principles of antidepressant efficacy. Human Psychopharmacology. Nutt, D. J. (2002). Tolerability and safety aspects of mirtazapine. . Human Psychopharmacology, 17 (Suppl. 1), S37–S41. Velazquez, C. C. (2001). Relative safety of mirtazapine overdose. Veterinary and Human Toxicology, 43, 342–344. Feighner, J. P. (1995). Cardiovascular safety in depressed patients: focus on venlafaxine. Journal of Clinical Psychiatry, 56, 574–579. Whyte, I. M. (2003). Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants. QJM, 96, 369–374 Buckley, N. A. (2002). Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of UK mortality data. British Medical Journal, 325, 1332–1333. MHRA. (2004). Report of the CSM Expert Working Group on the Safety of Selective Serotonin Reuptake Inhibitor Antidepressants. Obtenido de http://www.mhra. gov.uk/home/groups/pl-p/documents/drugsafetymessage/con019472.pdf Janowsky, D. C. (1983). Trazodone-aggravated ventricular arrhythmias. Journal of Clinical Psychopharmacology, 3, 372–376. Chong, S. A. (2001). Cardiac effects of psychotropic drugs. Annals, Academy of Medicine, Singapore, 30, 625–631. Reilly, J. G. (2000). QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet,, 1048–1052. Maneeton N, M. B. (2012). Quetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trials. BMC Psychiatry, 12:160. Marcus RN, M. R. (2008). The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study. J Clin Psychopharmacol , 28:156-65. Berman RM, M. R. (2007). The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebocontrolled study. . J Clin Psychiatry, 68:843-53. Nierenberg, A. A. (1995). Early nonresponse to fluoxetine as a predictor of poor 8-week outcome. American Journal of Psychiatry, 152, 1500–1503. Nierenberg, A. A. (2000). Timing of onsent of antidepressant response with fluoxetine treatment. American Journal of Psychiatry, 157, 1423–1428. Szegedi, A. J. (2009). Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients. Journal of Clinical Psychiatry,, 70, 344–353. Stassen, H. H.-S. (1993). Time course of improvement under antidepressant treatment: a survival-analytical approach. European Neuropsychopharmacology, 3, 127–135. Szegedi, A. M. (2003). Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression. Journal of Clinical Psychiatry,, 64, 413–420. Jakubovski E, V. A. (2016). Systematic review and meta-analysis: dose-response relationship of selective serotonin reuptake inhibitors in major depressive disorder. Am J Psychiatry, 173:174-83. Fava M, R. J. (1994). Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study. Am J Psychiatry , 151:1372-74. Perry PJ, Z. C. (1994). Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response. J Clin Psychopharmacol , 14:230-40. Nelson JC, M. C. (1991). A preliminary, open study of the combination of fluox- etine and desipramine for rapid treatment of major depression. Arch Gen Psychiatry, 48:303- 07. Taylor, D. (1995). Selective serotonin reuptake inhibitors and tricyclic antidepressants in combination. Interactions and therapeutic uses. British Journal of Psychiatry, 167, 575–580. McGrath, P. J. (1993). A double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depression. . American Journal of Psychiatry, 150, 118–123. Trivedi, M. H. (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STARD: implications for clinical practice. American Journal of Psychiatry, 163, 28–40 Dam J, R. L. (1998). Morning fluoxetine plus evening mianserin versus morning fluoxetine plus evening placebo in the acute treatment of major depression. Pharmacopsychiatry, 31:48-54. Maes M, L. I. (1999). Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance. . J Clinic Psychopharmacol, 19:177-82 Cappiello A, M. C. (1995). Yohimbine augmentation of fluvoxamine in refractory depression: a single-blind study. . Biol Psychiatry, 38:765-67 Schatzberg AF, R. A. (2005). Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not. Arch Gen Psychiatry, 62:513-20 Thase ME, F. E. (2007). Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STARD report. Am J Psychiatry, 164:739- 52. Bull SA, H. X. (2002). Discontinuation of use and switching of antidepressants: influence of patient-physician communication. JAMA , 288:1403-09 Thase ME, B. S. (1997). Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline. J Clin Psychiatry , 58:16-21 Brown WA, H. W. (1995J ). Are patients who are intolerant to one serotonin selective reuptake inhibitor intolerant to another? J Clin Psychiatry, 56:30-34. Alan J Lenox-Smith, Q. J. (2008). Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor. Int Clin Psychopharmacol ., 23(3):113-9 M F Poirier, P. B. (1999). Venlafaxine and paroxetine in treatment-resistant depression. Double-blind, randomised comparison. Br J Psychiatry ., 175:394 Bradley N Gaynes, A. J. (2008). The STARD study: Treating depression in the real world. Cleve Clin J Med ., 75(1):57-66 Rush, A. J. (2003). STARD treatment trial for depression. American Journal of Psychiatry, 160, 237 Psychiatrists, R. C. (1997). Benzodiazepines: Risks, Benefits or Dependence. A Reevaluation. . Council Report CR59. London: Royal College of Psychiatrists. Britain, B. M. (2009). British National Formulary (BNF 57). . London: British Medical Association and the Royal Pharmaceutical Society of Great Britain Dietrich, D. E. (1998). The use of anticonvulsants to augment antidepressant medication. Journal of Clinical Psychiatry, 59 (Suppl. 5), 51–58 Zhang, Z. J. (2008). The effectiveness of carbamazepine in unipolar depression: a double blind, randomised, placebo controlled study. Journal of Affective Disorders, 109, 91–97 Cullen, J. M. (1991). Carbamazepine for treatment- resistant melancholia. Journal of Clinical Psychiatry, 52, 472–476. Ketter, T. A. (1995). Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression. Journal of Clinical Psychiatry, 56, 471–475 Davis, L. L. (1996). Valproate as an antidepressant in major depressive disorder. Psychopharmacology Bulletin, 32, 647–652 Geddes, J. R. (2009). Lamotrigine for treatment of bipolar depression: independent metaanalysis and meta-regression of individual patient data from five randomised trials. British Journal of Psychiatry, 194, 4–9 Hurley, S. C. (2002). Lamotrigine update and its use in mood disorders. Annals of Pharmacotherapy, 36, 860–873 Normann, C. H. (2002). Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double-blind study. Journal of Clinical Psychiatry, 63, 337–344 Loosen, P. T. (1987). The TRH stimulation test in psychiatric disorders: a review. Handbook of Clinical Psychoneuroendocrinology (eds P. T. Loosen & C. B. Nemeroff ), pp. 336– 360 Maes, M. M. (1993). An evaluation of basal hypothalamic-pituitary-thyroid axis function in depression: results of a large- scaled and controlled study. Psychoneuroendocrinology, , 18, 607–620. Altshuler, L. L. (2001). Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature. American Journal of Psychiatry,, 158, 1617–1622 Steiner, M. R. (1978). Failure of L-triiodothyronine (T3) to potentiate tricyclic antidepressant response. Current Therapeutic Research, Clinical and Experimental, 23, 655–659 Gitlin, M. J. (1987). Failure of T3 to potentiate tricyclic antidepressant response. Journal of Affective Disorders, 13, 267–272. Thase, M. E. (1989). Treatment of imipramine-resistant recurrent depression. I: An open clinical trial of adjunctive L-triiodothyronine. Journal of Clinical Psychiatry, 50, 385– 388. Joffe, R. T. (1990). A comparison of triiodothyronine and thyroxine in the potentiation of tricyclic antidepressants. Psychiatry Research, 32, 241–251. Wisniewski, S. R. (2009). Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D Report. American Journal of Psychiatry, 166, 599–607 Schwartz TL, A. N. (2004). An open-label study of adjunctive modafinil in patients with seda- tion related to serotonergic antidepressant therapy. J Clin Psychiatry, 65:1223-27. Candy M, J. L. (2008). Psychostimulants for depression (review). Cochrane Database of Systematic Reviews, CD006722. Dunlop BW, C.-C. P. (2007). Coadministration of modafinil and a selective serotonin reuptake inhibitor from the initiation of treatment of major depressive disorder with fatigue and sleepi- ness: a double-blind, placebo-controlled study. J Clin Psychopharmacol, 27:614-19. Fava M, T. M. (2005). A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness. J Clin Psychiatry, 66:85-93 Wang F, L. E. (2014). The effects of tai chi on depression, anxiety, and psychological wellbeing: a systematic review and meta-analysis. Int J Behav Med , 21:605-17 Ravindran AV, L. R. (2009). Canadian network for mood and anxiety treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. V. complementary and alternative medicine treatments. J Affect Disord, 117:S54-64. L., L. (2014). The effectiveness of yoga for depression: a critical literature review. . Issues Ment Health Nurs, 35:265-76. Sniezek DP, S. I. (2013). Acupuncture for treating anxiety and depression in women: a clinical systematic review. Med Acupunct, 25:164-72. MacPherson H, R. S. (2013). Acupuncture and counselling for depression in primary care: a randomised controlled trial. PLoS Med, 10:e1001518. Freeman MP, F. M. (2010). Complementary and alternative medicine in major depressive disorder: the American psychiatric association task force report. J Clin Psychiatry, 71:669-81. Leppämäki SJ, P. T. (2002). Randomized trial of the efficacy of bright-light exposure and aerobic exercise on depressive symptoms and serum lipids. J Clin Psychiatry, 63:316-21 Golden RN, G. B. (2005). The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry, 162:656-62. Jorm AF, C. H. (2002). Effectiveness of complementary and self-help treat- ments for depression. Med J Aust, 176:S84-S96. Prasko J, H. J. (2002). Bright light therapy and/or imipramine for inpatients with recurrent non-seasonal depression. Neuro Endocrinol Lett , 23:109-13 Benedetti F, C. C. (2003). Morning light treatment hastens the antidepressant effect of citalopram: a placebo-controlled trial. J Clin Psychiatry, 64:648-53. Appleton KM, R. P. (2010). Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. Am J Clin Nutr, 91:757-70. Siwek M, D. D.-Z. (2010). Serum zinc level in depressed patients during zinc supplementation of imipramine treatment. J Affect Disord, 126:447-52. Colangelo LA, H. K. (2009). Higher dietary intake of long-chair w-3 polyunsaturated fatty acids is inversely associated with depressive symptoms in women. Nutrition, 25:1011-19 Bloch MH, H. J. (2012). Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis. Mol Psychiatry, 17:1272-82. Shaffer JA, E. D. (2014). Vitamin D supplementation for depressive symptoms: a systematic review and meta-analysis of randomized controlled trials. . Psychosom Med , 76:190-96. Li G, M. L. (2014). Efficacy of vitamin D supplementation in depression in adults: a systematic review. J Clin Endocrinol Metab, 99:757-67. Geddes JR, C. S. (2003). Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet , 361:653-61 Kellner, C. H. (2007). Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the consortium for research in electroconvulsive therapy (CORE). Archives of General Psychiatry, 63, 1337–1344 Lorena Rami, M. B. (2004). Absence of additional cognitive impairment in schizophrenia patients during maintenance electroconvulsive therapy. Schizophr Bull , 30(1):185- 9 Wijkstra, J. &. (2005). Successful maintenance electroconvulsive therapy for more than seven years. . Journal of ECT, 21, 171–173. Zisselman, M. H. (2007). Long-term weekly continuation electroconvulsive therapy: a case series. Journal of ECT, 23, 274–277. UK ECT Review Group, T. (2003). Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet, 361:799-808. Anderson EL, R. I. (2009). ECT in pregnancy: a review of the literature from 1941 to 2007. Psychosomatic Med , 71:235-42. Herrmann, L. L. (2006). actors modifying the efficacy of transcranial magnetic stimulation in the treatment of depression. Journal of Clinical Psychiatry, 67, 1870–1876. Raymond W Lam, P. C.-H. (2008). Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and metaanalysis. Can J Psychiatry ., 53(9):621-31. Harden, C. L. (2000). A pilot study of mood in epilepsy patients treated with vagus nerve stimulation. Epilepsy and Behavior, 1, 93–99. Linde K, B. M. (2008). St John's wort for major depression. Cochrane Database Syst Rev, CD000448. Smith CA, H. P. (2010). Acupuncture for depression. Cochrane Database Syst Rev, CD004046. Hausenblas HA, S. D. (2013). Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials. J Integr Med, 11:377-83. Improvement, I. f. (Noviembre de 2021). ICSI. Guidelines. Obtenido de https://www.icsi.org/guideline/depression/ Association, A. P. (Noviembre de 2021). APA- Approved Standards and Guidelines. Obtenido de https://www.apa.org/about/policy/approved-guidelines Excellence, N. I. (Noviembre de 2021). NICE guidelines. Obtenido de https://www.nice.org.uk/about/what-we-do/our-programmes/niceguidance/nice-guidelines David Taylor, T. R. (2021). The Maudsley. Prescribing Guidelines in Psychiatry. 13th Edition. West Sussex, PO19 8SQ, UK: The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK. Gilbody S, B. P. (2006). Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Arch Intern Med, 166:2314-21. Hunkeler EM, K. W. (2006). Long term outcomes from the IMPACT randomised trial for depressed elderly patients in primary care. BMJ, 332:259-63. Simon GE, K. W. (2001). Cost-effectiveness of a collaborative care program for primary care patients with persistent depression. Am J Psychiatry, 158:1638-44. Katon W, V. K. (1999). Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial. Arch Gen Psychiatry, 56:1109-15.
dc.rights.coar.fl_str_mv	http://purl.org/coar/access_right/c_abf2
dc.rights.license.spa.fl_str_mv	Atribución-NoComercial-SinDerivadas 4.0 Internacional
dc.rights.uri.spa.fl_str_mv	http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.accessrights.spa.fl_str_mv	info:eu-repo/semantics/openAccess
rights_invalid_str_mv	Atribución-NoComercial-SinDerivadas 4.0 Internacional http://creativecommons.org/licenses/by-nc-nd/4.0/ http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv	openAccess
dc.format.extent.spa.fl_str_mv	100 páginas
dc.format.mimetype.spa.fl_str_mv	application/pdf
dc.publisher.spa.fl_str_mv	Universidad Nacional de Colombia
dc.publisher.program.spa.fl_str_mv	Bogotá - Medicina - Especialidad en Psiquiatría
dc.publisher.department.spa.fl_str_mv	Departamento de Psiquiatría
dc.publisher.faculty.spa.fl_str_mv	Facultad de Medicina
dc.publisher.place.spa.fl_str_mv	Bogotá, Colombia
dc.publisher.branch.spa.fl_str_mv	Universidad Nacional de Colombia - Sede Bogotá
institution	Universidad Nacional de Colombia
bitstream.url.fl_str_mv	https://repositorio.unal.edu.co/bitstream/unal/81106/1/1020762424.2021%20-%20Luisa%20Fernanda%20Morales%20Pinilla.pdf https://repositorio.unal.edu.co/bitstream/unal/81106/2/license.txt https://repositorio.unal.edu.co/bitstream/unal/81106/3/1020762424.2021%20-%20Luisa%20Fernanda%20Morales%20Pinilla.pdf.jpg
bitstream.checksum.fl_str_mv	63d0af1542dd84f05c8b45ee80c52ef3 8153f7789df02f0a4c9e079953658ab2 2fa3f2798a5895146cdbae1a9b6ae4ee
bitstream.checksumAlgorithm.fl_str_mv	MD5 MD5 MD5
repository.name.fl_str_mv	Repositorio Institucional Universidad Nacional de Colombia
repository.mail.fl_str_mv	repositorio_nal@unal.edu.co
_version_	1814090035988791296
spelling	Atribución-NoComercial-SinDerivadas 4.0 Internacionalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Calvo, José Manuel79bccdf638c368bb9c95d749842960f9Carlos Fernando, Grillo Ardiladea0eacc1b508c0e5015bce6f1bf9939Morales Pinilla, Luisa Fernandaff9408346f4e654f5b31330a098bc73d2022-03-01T23:33:01Z2022-03-01T23:33:01Z2021https://repositorio.unal.edu.co/handle/unal/81106Universidad Nacional de ColombiaRepositorio Institucional Universidad Nacional de Colombiahttps://repositorio.unal.edu.co/ilustraciones, tablasLa atención oportuna y adecuada de las enfermedades más prevalentes, requiere entre otros aspectos, la implementación de estándares mínimos de atención en salud, que garanticen tanto a pacientes como a cuidadores, que se recibe y proporciona una atención segura, efectiva y eficiente. El presente documento, contiene las directrices metodológicas y las preguntas clínicas formuladas así como los lineamientos con una descripción breve de la evidencia que los soporta y que conforman el “PROTOCOLO BASADO EN LA EVIDENCIA PARA EL DIAGNÓSTICO Y TRATAMIENTO DEL PACIENTE ADULTO CON DEPRESIÓN EN EL HOSPITAL UNIVERSITARIO NACIONAL DE COLOMBIA. (Texto tomado de la fuente)The timely and adequate care of the most prevalent diseases requires, among other aspects, the implementation of minimum standards of health care, which guarantee both patients and caregivers that safe, effective and efficient care is received and provided. This document contains the methodological guidelines and the clinical questions formulated as well as the recommendations with a brief description of the evidence that supports them and that make up the "EVIDENCE-BASED PROTOCOL FOR THE DIAGNOSIS AND TREATMENT OF THE ADULT PATIENT WITH DEPRESSION IN THE COLOMBIA NATIONAL UNIVERSITY HOSPITAL”.Especialidades MédicasEspecialista en Psiquiatría100 páginasapplication/pdfspaUniversidad Nacional de ColombiaBogotá - Medicina - Especialidad en PsiquiatríaDepartamento de PsiquiatríaFacultad de MedicinaBogotá, ColombiaUniversidad Nacional de Colombia - Sede Bogotá610 - Medicina y salud::616 - EnfermedadesDepresiónDepressionDepresiónTrastorno depresivo recurrenteEpisodio depresivoProtocoloLineamientosDepressionRecurrent depressive disorderDepressive episodeProtocolRecommendationsProtocolo basado en la evidencia para el diagnóstico y tratamiento del paciente adulto con depresión en el Hospital Universitario Nacional de ColombiaEvidence-based protocol for the diagnosis and treatment of adult patients with depression at the Colombia National University HospitalTrabajo de grado - Especialidad Médicainfo:eu-repo/semantics/masterThesisinfo:eu-repo/semantics/acceptedVersionTexthttp://purl.org/redcol/resource_type/TMMinisterio de Sanidad, Servicios Sociales e Igualdad. (2014). Guía de Práctica Clínica Sobre el Manejo de la Depresión en el Adulto. Galicia: Agencia de Evaluación de Tecnologías Sanitarias de Galicia, avalia-t. Conselleria de Sanidad, Ministerio de Sanidad, Servicios Sociales e Igualdad.National Institute for Health & Clinical Excellence. (2019). DEPRESSION. The Nice Guideline On The Treatment And Management Of Depression In Adults. London: The British Psychological Society and The Royal College of Psychiatrists.Group, T. G. (2004). The Grading of Recommendations Assessment, Development and Evaluation. Obtenido de GRADE: https://www.gradeworkinggroup.org/Research, C. I. (2009). APPRAISAL OF GUIDELINES FOR RESEARCH & EVALUATION II. McMaster University, Hamilton, Ontario, Canada: AGREE Next Steps Consortium.Colombiano, G. d. (2014). Guía Metodológica para la elaboración de Guías de Práctica Clínica con Evaluación Económica en el Sistema General de Seguridad Social en Salud Colombiano. Obtenido de https://www.iets.org.co/Archivos/62/Gu%C3%ADa%20Metodol%C3%B3gica%20El aboraci%C3%B3n%20de%20GPC%20con%20Evaluaci%C3%B3n%20Econ%C3%B3mi ca%20en%20el%20Sist%20Seguridad%20Social%20y%20SaludVersi%C3%B3n%20final%20completa.PDFPatricia B. Burns, R. J. (2011). The Levels of Evidence and their role in Evidence-Based Medicine. Plast Reconstr Surg, 305-311.Vallejo-Ortega MT, S.-P. R.-A.-P.-S.-C. (2016). Manual Metodológico para la elaboración de protocolos clínicos en el Instituto Nacional de Cancerología. Bogotá: Instituto Nacional de Cancerología.James Atkinson, Y. C.-S. (2007). Natural Ventilation for Infection Control in Health-Care Settings. Switzerland: WHO Publication/Guidelines.Moussavi, S. C. (2007). Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet, 370, 851-858.Cassano, P. &. (2002). Depression and public health: an overview. . Journal of Psychosomatic Research, 53., 849-857.Heilbron, N., Compton, J., & Goldston, D. (2010, 41). The Problematic Label of Suicide Gesture: Alternatives for Clinical Research and Practice. Professional Psychology, Research and Practice, 221-227.Shea, S. C. (2002). La entrevista psiquiátrica. El arte de comprender. . Madrid, España.: Ediciones HarcourtPim Cuijpers, A. T. (March 14, 2012). Preventing Depression. A Global Priority. Journal of the American Medical Association., Vol 307, No. 10.Stockings EA, D. L. (2016). Preventing depression and anxiety in young people: a review of the joint efficacy of universal, selective and indicated prevention. Psychlogical Medicine, 46:11-26.Brugha, T. W. (2000). Pragmatic randomized trial of antenatal intervention to prevent post-natal depression by reducing psychosocial risk factors. Psychological Medicine, 30:1273-1281.Van Zoonen K, B. C. (2014). Preventing the onset of major depressive disorder: a metaanalytic review of psychological interventions. International Journal of Epidemiology., 43:318-329.Willemse GRWM, S. F. (2004). Minimal contact psychotherapy for sub-threshold depression in primary care: a randomised trial. Br J Psychiatry, 185:416-421.Van ’t Veer-Tazelaar PA, v. M. (2009). Stepped-care prevention of anxiety and depression in late life: a randomized controlled trial. . Archives of General Psychiatry, 66:297- 304Fornés Vives, J. (2003). Enfermeria en Salud Mental. Como cuidar al cuidador.Ian Colman, P. K. (2011, Nov 22). Predictors of long-term prognosis of depression. Canadian Medical Association Journal, 183(17): 1969-1976.Christoph Kraus, B. K. (2019). Prognosis and improved outcomes in major depression: a review. Translational Psychiatry, 9:127.Stahl, S. M. (2014). Psicofarmacología Esencial de Stahl. Guía del Prescriptor. Quinta Edición. New York, USA: Aulamédica. Formación en saludOrganización Mundial de la Salud. (Marzo de 2020). Temas de Salud: Depresión. Obtenido de Sitio Web Mundial. Organización Mundial de la Salud.: https://www.who.int/topics/depression/es/Organización Panamericana de la Salud. (30 de Marzo de 2017). "Depresión: hablemos", dice la OMS, mientras la depresión encabeza la lista de causas de enfermedad. Obtenido de OPS Web Site: https://www.paho.org/hq/index.php?option=com_content&view=article&id=1310 2:depression-lets-talk-says-who-as-depression-tops-list-of-causes-of-illhealth&Itemid=1926&lang=esOrganización Panamericana de la Salud, Oficina Sanitaria Panamericana. (1992). Clasificación Estadística Internacional de Enfermedades y Problemas Relacionados con la Salud. Décima Revisión. Washington, D.C. E.U.A: Oficina Regional de la Organización Mundial de la SaludMinisterio de Salud Y Protección Social de Colombia, Departamento Administrativo de Ciencia, Tecnología e Innovación. (2015). Encuesta Nacional de Salud Mental 2015 Tomo I. Bogotá, Colombia.Ministerio de Salud y Protección Social de Colombia, Colciencias. (2013). Guía de Práctica Clínica. Detección Temprana y Diagnóstico del Episodio Depresivo y Trastorno Depresivo Recurrente en Adultos. Bogotá, ColombiaAssociation, American Psychiatric. (2014). Manual Diagnóstico y Estadístico de los Trastornos Mentales. DSM-5. 5 Edición. Virginia, Estados Unidos.: Editorial Médica Panamericana.Ministerio de Salud y Protección Social de Colombia, SISPRO. (Marzo de 2020). Sistema Integrado de Información de la Protección Social, Observatorio Salud Mental. Obtenido de SISPRO Web Site: http://rssvr2.sispro.gov.co/ObsSaludMental/Ministerio de Salud y Protección Social, Pontificia Universidad Javeriana. . (2015). Depresión. Protocolo de Prevención y Actuacion en el Entorno Laboral. . Bogotá, Colombia.: Fundación Cultural Javeriana de Artes Gráficas - JAVEGRAFAgency for Healthcare Research and Quality U.S. Department of Health and Human Services. (2013). Screening ofr Suicide Risk in Primary Care: A Systematic Evidence Review for the U.S. Preventive Service Task Force. Portland: Agency for Healthcare Research and Quality U.S.World Health Organization. Regional Office for Europe. (2016). Preventing depression in the WHO European Region. Marmorvej, Copenhagen, Denmark: Netherlands Institute of Mental Health and Addiction. World Health OrganizationMinisterio de Salud y Protección Social. Organización Internacional para las Migraciones. (2015). Manual de Cuidado a Cuidadores de Personas con Trastornos Mentales y/o Enfermedades Crónicas Discapacitantes.Ministerio del Trabajo. (22 de Julio de 2019). Resolución Número 2404 de 2019. ColombiaMinisterio de Trabajo. (2015, Diciembre). Protocolo de Acciones de Promoción, Prevención e Intervención de los Factores Psicosociales y sus Efectos en el Entorno Laboral. Bogotá D.C, Colombia: Fundación Cultural Javeriana de Artes Gráficas - JAVEGRAF.ONU Migración, Ministerio de Salud y Protección Social. (s.f.). Clasificación Internacional del Funcionamiento, de la Discapacidad y de la Salud- CIF- Marco Conceptual de la Certificación y Registro de Discapacidad. Creative CommonsThe American Psychological Association . (2019). Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts American Psychological Association Guideline Development Panel for the Treatment of Depressive Disorders. NE, Washington D.C.: The American Psychological Association (APA)Improvement, I. f. (2016). Adult Depression in Primary Care. ICSI Health Care GuidelineKroenke K, S. R. (2001). he PHQ-9: validity of a brief depression severity measure. J Gen Intern Med , 16:606-13.O'Connor AM, B. C. (2007). Do patient decision aids meet effectiveness criteria of the international patient decision aid standards collaboration? A systematic review and meta-analysis. Med Decis Making, 27:554-74.Brown, R. A. (1984). A psychoeducational approach to the treatment of depression: Comparison of group, individual, and minimal contact procedures. . Journal of Consulting and Clinical Psychology, 52(5), 774–783.Richards, D. A. (2008). Collaborative care for depression in UK primary care: a randomized comtrolled trial. Psychological Medicine, 38, 279–287.Williams, J. M. (2008). Mindfulness-based cognitive therapy: further issues in current evidence and future research. Journal of Consulting and Clinical Psychology, 76, 524–529.Christensen, H. G. (2004). Delivering interventions for depression by using the internet: randomised controlled trial. British Medical Journal, 328, 265–268.Spek, V. (2007). Internet-based cognitive behaviour therapy for subthreshold depression in people over 50 years old. Ridderprint.McCrone, P. C. (2003). Cost- utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy. European Journal of Neurology, 10, 687–694.Kaltenthaler, E. P. (2008). Computerised cognitive- behavioural therapy for depression: systematic review. British Journal of Psychiatry, 193, 181–184Dunn AL, M. H. (2005). Exercise treatment for depression: efficacy and dose response. Am J Prev Med, 28:1-8Babyak M, B. J. (2000). Exercise treatment for major depression: maintenance of therapeutic benefit at 10 months. Psychosom Med, 62:633-38.Schuch FB, V.-M. M. (2011). Exercise and severe depression: prelimi- nary results of an add-on study. . J Affect Disord, 133:615-18.Cooney GM, D. K. (2013). Exercise for depression. Cochrane Database of Systematic Reviews , CD004366.Cuijpers P, S. M. (2014b). Adding psychotherapy to antidepressant medication in depression and anxiety disorders: a meta-analysis. World Psychiatry, 13:56-67.Churchill R, M. T. (2013). 'Third wave' cognitive and behavioural therapies versus treatments as usual for depression. Cochrane Database Syst Rev, (10)CD008705.van Hees ML, R. T. (2013). The effectiveness of individual interpersonal psycho- therapy as a treatment for major depressive disorder in adult outpatients: a systematic review. BMC Psychiatry , 13:22Jakobsen JC, H. J. (2012a). Effects of cognitive therapy versus interpersonal psychotherapy in patients with major depressive disorder: a systematic review of randomized clinical trials with meta-analyses and trial sequential analyses. . Psychol Med , 42:1343-57.McCarney RW, S. J. (2012). Effectiveness of mindfulness-based therapies in reducing symptoms of depression: a meta-analysis. Eur J Psychotherapy Couns, 14:279-99.Pim Cuijpers, T. D. (2011b). Self-Guided Psychological Treatment for Depressive Symptoms: A Meta-Analysis. Plos One.Jakobsen JC, H. J. (2011a). The effect of interpersonal psychotherapy and other psychodynamic therapies versus 'treatment as usual' in patients with major depressive disorder. PLoS One , 6:e19044.Flückiger C, D. R. (2014). Enduring effects of evidence-based psychotherapies in acute depression and anxiety disorders versus treatment as usual at follow-up: a longitudinal meta-analysis. Clin Psychol Rev, 34:367-75.Okumura Y, I. K. (2014). Efficacy and acceptability of group cognitive behavioral therapy for depression: a systematic review and meta-analysis. J Affect Disord , 164:155-64.JAN SCOTT, S. P. (2003). Use of cognitive therapy for relapse prevention in chronic depression in chronic depression Cost-effectiveness study . BRITI SH JOURNA L O F P SYCHIATRY, 182, 221-227.Charles F. Reynolds III, M., Ellen Frank, P., James M. Perel, P., & al, e. (1999). Nortriptyline and Interpersonal Psychotherapy as Maintenance Therapies for Recurrent Major Depression. JAMA, 281(1):39-45.H C Schulberg 1, M. R. (1996). Treating major depression in primary care practice. Eightmonth clinical outcomes. Arch Gen Psychiatry ., 53(10):913-9.Frank, E. &. (1990). Interpersonal psychotherapy for depression: Overview, clinical efficacy, and future directions. Clinical Psychology: Science and Practice, 2(4), 349– 369.Mazzucchelli T, K. R. (2009). Behavioral activation treatments for depression in adults: a meta- analysis and review. Cin Psychol Sci Prac , 16:383-411Pim Cuijpers, A. v. (2007). Behavioral activation treatments of depression: a meta-analysis. Clin Psychol Rev ., 27(3):318-26.Sona Dimidjian, S. D. (2006). Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol ., 74(4):658-70.Pim Cuijpers, G. A. (2011a). Psychological treatment of depression: results of a series of meta-analyses. Nord J Psychiatry, 65(6):354-64.Sheffield, J. S. (2006). Evaluation of universal, indicated, and combined cognitivebehavioral approaches to the prevention of depression among adlescents. Journal of Consulting and Clinical Psychology., 74:66-79.Pim Cuijpers, E. K. (2014a). Managing depression in older age: psychological interventions. Epub.Guy Bodenmann, B. P. (2008). Effects of coping-oriented couples therapy on depression: a randomized clinical trial. J Consult Clin Psychol ., 76(6):944-54.N Bedi, C. C. (2000). Assessing effectiveness of treatment of depression in primary care. Partially randomised preference trial. Br J Psychiatry ., 177:312-8.Jeanne C Watson, L. B. (2003). Comparing the effectiveness of process-experiential with cognitive-behavioral psychotherapy in the treatment of depression. J Consult Clin Psychol . , 71(4):773-81RHONDA N. GOLDMAN, L. S. (2006). The effects of adding emotion-focused interventions to the therapeutic relationship in the treatment of depression. Psychotherapy Research , 16(5):537-549.Greenberg, L. S. (1998). Experiential therapy of depression: Differential effects of clientcentered relationship conditions and process experiential interventions. . Psychotherapy Research, 8(2), 210–224.Friedli, K. K. (2000). The economics of employing a counsellor in general practice: analysis of data from a randomised controlled trial. British Journal of General Practice, 50, 276–283.Simpson, S. C. (2003). A randomized controlled trial to evaluate the effectiveness and costeffectiveness of psychodynamic counselling for general practice patients with chronic depression. Psychological Medicine, 33, 229–239.Van, H. L. (2008). Predicting the outcome of antidepressants and psychotherapy for depression: a qualitative, systematic review. . Harvard Review of Psychiatry, 16, 225–234.Jouko K Salminen, H. K.-H. (2008). Short-term psychodynamic psychotherapy and fluoxetine in major depressive disorder: a randomized comparative study. Psychother Psychosom ., 77(6):351-7.McLean, P. D. (1979). Clinical depression: Comparative efficacy of outpatient treatments. Journal of Consulting and Clinical Psychology, 47(5), 818–836.Giuseppe Maina, G. R. (2008). Brief dynamic therapy combined with pharmacotherapy in the treatment of major depressive disorder: long-term results. J Affect Disord ., 114(1-3):200-7Kool, S. D. (2003). Changes in personality pathology after pharmacotherapy and combined therapy for depressed patients. Journal of Personality Disorders, 17(1), 60–72.Association, A. P. (2010). PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder. American Psychiatric Association.Katon W, R. P. (1996). A multifaceted intervention to improve treatment of depression in primary care. . Arch Gen Psychiatry, 53:924-32Fournier JC, D. R. (2010). Antidepressant drug effects and depression severity: a patientlevel meta-analysis. . JAMA, 303:47-53.Keller MB, K. J. (1998). Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial. JAMA, 280:1665-72.RMA., H. (2001). Clinical importance of long-term antidepressant treatment. Br J Psychiatry Suppl, 179:S4-S8.JF., G. (1993). Antidepressant maintenance medications: when to discontinue and how to stop. J Clin Psychiatry , 54:39-47.Trivedi MH, K. B. (2001). Algorithm for the treatment of chronic depression. J Clin Psychiatry , 62:22- 29.Barbey, J. T. (1998). SSRI safety in overdose. Journal of Clinical Psychiatry,, 59 (Suppl. 15), 42–48.Goeringer, K. E. (2000). Post mortem forensic toxicology of selective serotonin reuptake inhibitors: a review of pharmacology and report of 168 cases. . Journal of Forensic Sciences,, 45, 633–648.Cohen, H. W. (2000). Excess risk of myocardial infarction in patients treated with antidepressant medication: association with use of tricyclic agents. American Journal of Medicine, 108, 2–8.Meier, C. R. (2001). Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction. British Journal of Clinical Pharmacology, 52, 179–184.Sauer, W. H. (2001). elective serotonin reuptake inhibitors and myocardial infarction. Circulation, 104, 1894–1898Musselman, D. L. (1998). The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Archives of General Psychiatry, 55, 580–592.Pollock, B. G.-T. (2000). Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. Journal of Clinical Psychopharmacology, 20, 137–140.Rasmussen, S. L. (1999). Cardiac safety of citalopram: prospective trials and retrospective analyses. Journal of Clinical Psycho- pharmacology, , 19, 407–415.Zivin K, P. P. (2013). Evaluation of the FDA warning against prescribing citalopram at doses exceeding 40 mg. Am J Psychiatry, 170:642-50Zivin K, P. P. (2013). Evaluation of the FDA warning against prescribing citalopram at doses exceeding 40 mg. Am J Psychiatry, 170:642-50Steven P. Roosen, M., & and Kristen M. Suthers, M. (1998). Antidepressant Response in Late-life Depression. J Clinic Psychiatry, 59 (Suppl 10).Strik, J. J. (2000). Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebocontrolled trial. Psychosomatic Medicine, 62, 783–789.Hewer, W. R. (1995). Cardiovascular effects of fluvoxamine and maprotiline antidepressant treatment: effects on cognitive function and psychomotor performance. International Clinical Psychopharmacology, 15, 305–318Garnier, R. A. (1993). Acute fluvoxamine poisoning. Journal of International Medical Research, 21, 197–208.Glassman, A. H. (2002). Sertraline treatment of major depression in patients with acute MI or unstable angina. Journal of the American Medical Association, 288, 701–709.Cipriani, A. F. (2009). Comparative efficacy and acceptability of 12 new generation antidepressants: a multiple treatments meta- analysis. The Lancet, 373, 746–758.Roose, S. P. (1989). Cardiovascular effects of tricyclic antidepressants in depressed patients with and without heart disease. Journal of Clinical Psychiatry Monograph, 7, 1–19.Glassman, A. H. (1993). The safety of tricyclic antidepressants in cardiac patients. Risk– benefit reconsidered. Journal of the American Medical Association, 269, 2673– 2675.Roose, S. P. (1987). Tricyclic antidepressants in depressed patients with cardiac conduction disease. Archives of General Psychiatry, 44, 273–275.Shah, R. U. (2001). Trends in deaths from drug overdose and poisoning in England and Wales 1993–1998. Journal of Public Health Medicine, 23, 242–246.A Wade, K. G. (2007). A comparative study of the efficacy of acute and continuation treatment with escitalopram versus duloxetine in patients with major depressive disorder. Curr Med Res Opin ., Jul;23(7):1605-14.Schatzberg, A. F. (2002). Pharmacological principles of antidepressant efficacy. Human Psychopharmacology.Nutt, D. J. (2002). Tolerability and safety aspects of mirtazapine. . Human Psychopharmacology, 17 (Suppl. 1), S37–S41.Velazquez, C. C. (2001). Relative safety of mirtazapine overdose. Veterinary and Human Toxicology, 43, 342–344.Feighner, J. P. (1995). Cardiovascular safety in depressed patients: focus on venlafaxine. Journal of Clinical Psychiatry, 56, 574–579.Whyte, I. M. (2003). Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants. QJM, 96, 369–374Buckley, N. A. (2002). Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of UK mortality data. British Medical Journal, 325, 1332–1333.MHRA. (2004). Report of the CSM Expert Working Group on the Safety of Selective Serotonin Reuptake Inhibitor Antidepressants. Obtenido de http://www.mhra. gov.uk/home/groups/pl-p/documents/drugsafetymessage/con019472.pdfJanowsky, D. C. (1983). Trazodone-aggravated ventricular arrhythmias. Journal of Clinical Psychopharmacology, 3, 372–376.Chong, S. A. (2001). Cardiac effects of psychotropic drugs. Annals, Academy of Medicine, Singapore, 30, 625–631.Reilly, J. G. (2000). QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet,, 1048–1052.Maneeton N, M. B. (2012). Quetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trials. BMC Psychiatry, 12:160.Marcus RN, M. R. (2008). The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study. J Clin Psychopharmacol , 28:156-65.Berman RM, M. R. (2007). The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebocontrolled study. . J Clin Psychiatry, 68:843-53.Nierenberg, A. A. (1995). Early nonresponse to fluoxetine as a predictor of poor 8-week outcome. American Journal of Psychiatry, 152, 1500–1503.Nierenberg, A. A. (2000). Timing of onsent of antidepressant response with fluoxetine treatment. American Journal of Psychiatry, 157, 1423–1428.Szegedi, A. J. (2009). Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients. Journal of Clinical Psychiatry,, 70, 344–353.Stassen, H. H.-S. (1993). Time course of improvement under antidepressant treatment: a survival-analytical approach. European Neuropsychopharmacology, 3, 127–135.Szegedi, A. M. (2003). Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression. Journal of Clinical Psychiatry,, 64, 413–420.Jakubovski E, V. A. (2016). Systematic review and meta-analysis: dose-response relationship of selective serotonin reuptake inhibitors in major depressive disorder. Am J Psychiatry, 173:174-83.Fava M, R. J. (1994). Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study. Am J Psychiatry , 151:1372-74.Perry PJ, Z. C. (1994). Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response. J Clin Psychopharmacol , 14:230-40.Nelson JC, M. C. (1991). A preliminary, open study of the combination of fluox- etine and desipramine for rapid treatment of major depression. Arch Gen Psychiatry, 48:303- 07.Taylor, D. (1995). Selective serotonin reuptake inhibitors and tricyclic antidepressants in combination. Interactions and therapeutic uses. British Journal of Psychiatry, 167, 575–580.McGrath, P. J. (1993). A double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depression. . American Journal of Psychiatry, 150, 118–123.Trivedi, M. H. (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STARD: implications for clinical practice. American Journal of Psychiatry, 163, 28–40Dam J, R. L. (1998). Morning fluoxetine plus evening mianserin versus morning fluoxetine plus evening placebo in the acute treatment of major depression. Pharmacopsychiatry, 31:48-54.Maes M, L. I. (1999). Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance. . J Clinic Psychopharmacol, 19:177-82Cappiello A, M. C. (1995). Yohimbine augmentation of fluvoxamine in refractory depression: a single-blind study. . Biol Psychiatry, 38:765-67Schatzberg AF, R. A. (2005). Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not. Arch Gen Psychiatry, 62:513-20Thase ME, F. E. (2007). Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STARD report. Am J Psychiatry, 164:739- 52.Bull SA, H. X. (2002). Discontinuation of use and switching of antidepressants: influence of patient-physician communication. JAMA , 288:1403-09Thase ME, B. S. (1997). Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline. J Clin Psychiatry , 58:16-21Brown WA, H. W. (1995J ). Are patients who are intolerant to one serotonin selective reuptake inhibitor intolerant to another? J Clin Psychiatry, 56:30-34.Alan J Lenox-Smith, Q. J. (2008). Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor. Int Clin Psychopharmacol ., 23(3):113-9M F Poirier, P. B. (1999). Venlafaxine and paroxetine in treatment-resistant depression. Double-blind, randomised comparison. Br J Psychiatry ., 175:394Bradley N Gaynes, A. J. (2008). The STARD study: Treating depression in the real world. Cleve Clin J Med ., 75(1):57-66Rush, A. J. (2003). STARD treatment trial for depression. American Journal of Psychiatry, 160, 237Psychiatrists, R. C. (1997). Benzodiazepines: Risks, Benefits or Dependence. A Reevaluation. . Council Report CR59. London: Royal College of Psychiatrists.Britain, B. M. (2009). British National Formulary (BNF 57). . London: British Medical Association and the Royal Pharmaceutical Society of Great BritainDietrich, D. E. (1998). The use of anticonvulsants to augment antidepressant medication. Journal of Clinical Psychiatry, 59 (Suppl. 5), 51–58Zhang, Z. J. (2008). The effectiveness of carbamazepine in unipolar depression: a double blind, randomised, placebo controlled study. Journal of Affective Disorders, 109, 91–97Cullen, J. M. (1991). Carbamazepine for treatment- resistant melancholia. Journal of Clinical Psychiatry, 52, 472–476.Ketter, T. A. (1995). Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression. Journal of Clinical Psychiatry, 56, 471–475Davis, L. L. (1996). Valproate as an antidepressant in major depressive disorder. Psychopharmacology Bulletin, 32, 647–652Geddes, J. R. (2009). Lamotrigine for treatment of bipolar depression: independent metaanalysis and meta-regression of individual patient data from five randomised trials. British Journal of Psychiatry, 194, 4–9Hurley, S. C. (2002). Lamotrigine update and its use in mood disorders. Annals of Pharmacotherapy, 36, 860–873Normann, C. H. (2002). Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double-blind study. Journal of Clinical Psychiatry, 63, 337–344Loosen, P. T. (1987). The TRH stimulation test in psychiatric disorders: a review. Handbook of Clinical Psychoneuroendocrinology (eds P. T. Loosen & C. B. Nemeroff ), pp. 336– 360Maes, M. M. (1993). An evaluation of basal hypothalamic-pituitary-thyroid axis function in depression: results of a large- scaled and controlled study. Psychoneuroendocrinology, , 18, 607–620.Altshuler, L. L. (2001). Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature. American Journal of Psychiatry,, 158, 1617–1622Steiner, M. R. (1978). Failure of L-triiodothyronine (T3) to potentiate tricyclic antidepressant response. Current Therapeutic Research, Clinical and Experimental, 23, 655–659Gitlin, M. J. (1987). Failure of T3 to potentiate tricyclic antidepressant response. Journal of Affective Disorders, 13, 267–272.Thase, M. E. (1989). Treatment of imipramine-resistant recurrent depression. I: An open clinical trial of adjunctive L-triiodothyronine. Journal of Clinical Psychiatry, 50, 385– 388.Joffe, R. T. (1990). A comparison of triiodothyronine and thyroxine in the potentiation of tricyclic antidepressants. Psychiatry Research, 32, 241–251.Wisniewski, S. R. (2009). Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D Report. American Journal of Psychiatry, 166, 599–607Schwartz TL, A. N. (2004). An open-label study of adjunctive modafinil in patients with seda- tion related to serotonergic antidepressant therapy. J Clin Psychiatry, 65:1223-27.Candy M, J. L. (2008). Psychostimulants for depression (review). Cochrane Database of Systematic Reviews, CD006722.Dunlop BW, C.-C. P. (2007). Coadministration of modafinil and a selective serotonin reuptake inhibitor from the initiation of treatment of major depressive disorder with fatigue and sleepi- ness: a double-blind, placebo-controlled study. J Clin Psychopharmacol, 27:614-19.Fava M, T. M. (2005). A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness. J Clin Psychiatry, 66:85-93Wang F, L. E. (2014). The effects of tai chi on depression, anxiety, and psychological wellbeing: a systematic review and meta-analysis. Int J Behav Med , 21:605-17Ravindran AV, L. R. (2009). Canadian network for mood and anxiety treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. V. complementary and alternative medicine treatments. J Affect Disord, 117:S54-64.L., L. (2014). The effectiveness of yoga for depression: a critical literature review. . Issues Ment Health Nurs, 35:265-76.Sniezek DP, S. I. (2013). Acupuncture for treating anxiety and depression in women: a clinical systematic review. Med Acupunct, 25:164-72.MacPherson H, R. S. (2013). Acupuncture and counselling for depression in primary care: a randomised controlled trial. PLoS Med, 10:e1001518.Freeman MP, F. M. (2010). Complementary and alternative medicine in major depressive disorder: the American psychiatric association task force report. J Clin Psychiatry, 71:669-81.Leppämäki SJ, P. T. (2002). Randomized trial of the efficacy of bright-light exposure and aerobic exercise on depressive symptoms and serum lipids. J Clin Psychiatry, 63:316-21Golden RN, G. B. (2005). The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry, 162:656-62.Jorm AF, C. H. (2002). Effectiveness of complementary and self-help treat- ments for depression. Med J Aust, 176:S84-S96.Prasko J, H. J. (2002). Bright light therapy and/or imipramine for inpatients with recurrent non-seasonal depression. Neuro Endocrinol Lett , 23:109-13Benedetti F, C. C. (2003). Morning light treatment hastens the antidepressant effect of citalopram: a placebo-controlled trial. J Clin Psychiatry, 64:648-53.Appleton KM, R. P. (2010). Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. Am J Clin Nutr, 91:757-70.Siwek M, D. D.-Z. (2010). Serum zinc level in depressed patients during zinc supplementation of imipramine treatment. J Affect Disord, 126:447-52.Colangelo LA, H. K. (2009). Higher dietary intake of long-chair w-3 polyunsaturated fatty acids is inversely associated with depressive symptoms in women. Nutrition, 25:1011-19Bloch MH, H. J. (2012). Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis. Mol Psychiatry, 17:1272-82.Shaffer JA, E. D. (2014). Vitamin D supplementation for depressive symptoms: a systematic review and meta-analysis of randomized controlled trials. . Psychosom Med , 76:190-96.Li G, M. L. (2014). Efficacy of vitamin D supplementation in depression in adults: a systematic review. J Clin Endocrinol Metab, 99:757-67.Geddes JR, C. S. (2003). Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet , 361:653-61Kellner, C. H. (2007). Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the consortium for research in electroconvulsive therapy (CORE). Archives of General Psychiatry, 63, 1337–1344Lorena Rami, M. B. (2004). Absence of additional cognitive impairment in schizophrenia patients during maintenance electroconvulsive therapy. Schizophr Bull , 30(1):185- 9Wijkstra, J. &. (2005). Successful maintenance electroconvulsive therapy for more than seven years. . Journal of ECT, 21, 171–173.Zisselman, M. H. (2007). Long-term weekly continuation electroconvulsive therapy: a case series. Journal of ECT, 23, 274–277.UK ECT Review Group, T. (2003). Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet, 361:799-808.Anderson EL, R. I. (2009). ECT in pregnancy: a review of the literature from 1941 to 2007. Psychosomatic Med , 71:235-42.Herrmann, L. L. (2006). actors modifying the efficacy of transcranial magnetic stimulation in the treatment of depression. Journal of Clinical Psychiatry, 67, 1870–1876.Raymond W Lam, P. C.-H. (2008). Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and metaanalysis. Can J Psychiatry ., 53(9):621-31.Harden, C. L. (2000). A pilot study of mood in epilepsy patients treated with vagus nerve stimulation. Epilepsy and Behavior, 1, 93–99.Linde K, B. M. (2008). St John's wort for major depression. Cochrane Database Syst Rev, CD000448.Smith CA, H. P. (2010). Acupuncture for depression. Cochrane Database Syst Rev, CD004046.Hausenblas HA, S. D. (2013). Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials. J Integr Med, 11:377-83.Improvement, I. f. (Noviembre de 2021). ICSI. Guidelines. Obtenido de https://www.icsi.org/guideline/depression/Association, A. P. (Noviembre de 2021). APA- Approved Standards and Guidelines. Obtenido de https://www.apa.org/about/policy/approved-guidelinesExcellence, N. I. (Noviembre de 2021). NICE guidelines. Obtenido de https://www.nice.org.uk/about/what-we-do/our-programmes/niceguidance/nice-guidelinesDavid Taylor, T. R. (2021). The Maudsley. Prescribing Guidelines in Psychiatry. 13th Edition. West Sussex, PO19 8SQ, UK: The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK.Gilbody S, B. P. (2006). Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Arch Intern Med, 166:2314-21.Hunkeler EM, K. W. (2006). Long term outcomes from the IMPACT randomised trial for depressed elderly patients in primary care. BMJ, 332:259-63.Simon GE, K. W. (2001). Cost-effectiveness of a collaborative care program for primary care patients with persistent depression. Am J Psychiatry, 158:1638-44.Katon W, V. K. (1999). Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial. Arch Gen Psychiatry, 56:1109-15.InvestigadoresPadres y familiasPersonal de apoyo escolarPúblico generalORIGINAL1020762424.2021 - Luisa Fernanda Morales Pinilla.pdf1020762424.2021 - Luisa Fernanda Morales Pinilla.pdfTesis de especialidad medica en Psiquiatríaapplication/pdf965411https://repositorio.unal.edu.co/bitstream/unal/81106/1/1020762424.2021%20-%20Luisa%20Fernanda%20Morales%20Pinilla.pdf63d0af1542dd84f05c8b45ee80c52ef3MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-84074https://repositorio.unal.edu.co/bitstream/unal/81106/2/license.txt8153f7789df02f0a4c9e079953658ab2MD52THUMBNAIL1020762424.2021 - Luisa Fernanda Morales Pinilla.pdf.jpg1020762424.2021 - Luisa Fernanda Morales Pinilla.pdf.jpgGenerated Thumbnailimage/jpeg3483https://repositorio.unal.edu.co/bitstream/unal/81106/3/1020762424.2021%20-%20Luisa%20Fernanda%20Morales%20Pinilla.pdf.jpg2fa3f2798a5895146cdbae1a9b6ae4eeMD53unal/81106oai:repositorio.unal.edu.co:unal/811062024-08-03 23:10:45.924Repositorio Institucional Universidad Nacional de Colombiarepositorio_nal@unal.edu.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

Protocolo basado en la evidencia para el diagnóstico y tratamiento del paciente adulto con depresión en el Hospital Universitario Nacional de Colombia

Publicaciones similares